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Off- Versus On-Pump Coronary Surgery and the Effect of Follow-Up
Length and Surgeons’ Experience: A Meta-Analysis
Mario Gaudino, MD; Umberto Benedetto, PhD; Faisal Bakaeen, MD; Mohamed Rahouma, MD; Derrick Y. Tam, MD;
Ahmed Abouarab, MD; Antonino Di Franco, MD; Jeremy Leonard, MD; Adham Elmously, MD; John D. Puskas, MD;
Gianni D. Angelini, MD; Leonard N. Girardi, MD; Stephen E. Fremes, MD; David P. Taggart, PhD
Background-—The debate on the relative beneﬁts of off-pump and on-pump coronary artery bypass surgery (OPCABG and
ONCABG) is still open. We aimed to provide an updated and complete summary of the evidence on the differences between
OPCABG and ONCABG and to explore whether the length of the follow-up and the surgeons’ experience in OPCABG modify the
comparative results.
Methods and Results-—All randomized clinical trials comparing OPCABG and ONCABG were included. Primary outcome was follow-
up mortality. Secondary outcomes were operative mortality, perioperative stroke, perioperative myocardial infarction, and late
repeated revascularization. Subgroup analyses were performed based on the length of the follow-up and the percentage of crossover
from the OPCABG group (used as a surrogate of surgeon experience with OPCABG). One hundred four trials were included (20 627
patients, OPCABG: 10 288; ONCABG: 10 339). Weighted mean follow-up time was 3.7 years (range 1–7.5 years). OPCABG was
associated with a higher risk of follow-up mortality (incidence rate ratio 1.11, 95% conﬁdence interval 1.00–1.23, P=0.05). The
difference was signiﬁcant only for trials with mean follow-up of ≥3 years and for studies with a crossover rate of ≥10%. There was a
trend toward lower risk of perioperative stroke and higher need for late repeated revascularization in the OPCABG arm.
Conclusions-—OPCABG is associated with a higher incidence of incomplete revascularization, an increased need for repeated
revascularization, and decreased midterm survival compared with ONCABG. Surgeon inexperience in OPCABG is associated with
late mortality. ( J Am Heart Assoc. 2018;7:e010034. DOI: 10.1161/JAHA.118.010034.)
Key Words: coronary artery bypass • coronary artery bypass grafting •myocardial revascularization • off-pump coronary artery
bypass grafting • off-pump surgery • revascularization
C oronary artery disease is the most common cause ofdeath worldwide, and coronary artery bypass grafting
(CABG) remains the most effective mode of revascularization
for those with severe and extensive disease.1 Concerns for
perioperative neurological events from aortic cross-clamping
and the detrimental effects of cardiopulmonary bypass has
spurred much research into techniques to improve the safety
and efﬁcacy of CABG. Off-pump CABG (OPCABG) has emerged
as a potential solution to address these concerns. However,
despite nearly 2 decades of debate, 115 randomized clinical
trials (RCTs), and 62 meta-analyses, the controversy regarding
the beneﬁts and risks of OPCABG compared with on-pump
CABG (ONCABG) continues.2 Recently, 2 large RCTs comparing
on to off-pump CABG, the ROOBY (Randomized On/Off Bypass)
and CORONARY (CABG Off or On Pump Revascularization
Study) trials, published their 5-year results, eliciting further
controversy.3,4 In fact, ROOBY showed reduced survival in
OPCABG, whereas CORONARY showed lack of difference in
long-term outcome between the 2 arms.
The ROOBY trial, however, has been criticized for having
less strict case requirements for surgeons performing
OPCABG (the mean and median number of cases of OPCABG
performed by surgeons in other large RCTs were higher than
that of ROOBY).
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The publication of these 2 important and large clinical trials
warrants an updated meta-analysis of all the current available
RCT evidence to determine the potential risk and beneﬁts to
OPCABG to ONCABG. Furthermore, technical and biological
explanations for the divergence in outcomes seen in these
recent clinical trials have not yet been fully elucidated.
The objectives of this analysis were as follows:
1. to provide the most complete and rigorous evaluation of
the differences in early and late outcomes between
ONCABG and OPCABG.
2. to explore whether the length of the follow-up, the
surgeons’ experience in OPCABG, and the degree of
incomplete revascularization in the OPCABG arm impact
the comparative results between the 2 techniques.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Search Strategy and Study Selection
This systematic review was conducted in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.5
PubMed and OVID’s version of MEDLINE archives were
searched from inception to August 2017 for publications
comparing ONCABG versus OPCABG surgeries. The following
keywords were combined with the Boolean operator “or:”
“Coronary Artery Bypass,” “CABG,” “aorto coronary bypass,”
“aorto coronary anastomosis,” “aorto coronary,” “bypass or
graft,” “coronary,” “revascularization or revascularisation or
cardiopulmonary bypass,” “on pump or on-pump,” “off-Pump,”
“off pump or off-pump or OPCAB,” “beating heart.” The full
search strategy can be found in Data S1. All citations were
screened for study inclusion independently by 2 investigators
(AA and JL). Any disagreements were discussed and resolved
by consensus with a third investigator (MG). In addition, the
bibliography of all studies and meta-analyses were searched
to identify further publications.
Inclusion criteria were the following:
1 RCTs comparing OPCABG and ONCABG in patients with
multivessel coronary disease reporting any outcome and
with any follow-up duration.
2 Full-text articles written in the English language.
Studies reporting different outcomes from the same trial were
classiﬁed together.
Risk of bias among included trials were appraised by 2
independent investigators (UB and ADF) based on the “risk
of bias assessment tool” provided by the Cochrane
collaboration,6 in which 7 domains were assessed for each
RCT: random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and
personnel (performance bias), blinding of outcome assessors
(detection bias), incomplete outcome data (attrition bias),
selective reporting (reporting bias), and presence of other
bias. The presence of a possible source of bias in each domain
was assessed, and a ﬁnal judgment of low, unclear, or high
risk of bias was assigned.
Data Abstraction
Two investigators (AA and MG) independently abstracted the
following: study demographics (study period, country, centers
involved, sample size), patient characteristics (age, sex,
dyslipidemia, hypertension, diabetes mellitus, ejection frac-
tion, urgency, prior cerebrovascular accident, prior percuta-
neous intervention, previous myocardial infarction (MI), and
peripheral vascular disease), mean follow-up, operative char-
acteristics (diseased vessels, left main disease, number of
grafts per patient, mean number of arterial grafts per patient,
distal anastomosis, completeness of revascularization, cross-
over rates in OPCABG).
The deﬁnitions used by the authors in the original articles
were used for all the abstracted variables.
Continuous variables were expressed as median (interquar-
tile range) or as meanSD. Categorical variables were
reported as frequency (%).
Risk difference (RD) was used in preference to odds ratio
for the short-term outcomes because of the high number of
studies with zero events in both comparison arms. The
Clinical Perspective
What Is New?
• Off-pump coronary artery bypass surgery is associated with
a higher incidence of incomplete revascularization, an
increased need for repeated revascularization, and
decreased midterm survival compared with on-pump coro-
nary artery bypass surgery.
• Surgeon inexperience in off-pump coronary artery bypass
surgery is associated with late mortality.
What Are the Clinical Implications?
• Surgeon’s experience in off-pump coronary artery bypass
surgery may be associated with late mortality.
• We hypothesize that off-pump coronary artery bypass
surgery can be comparable to on-pump coronary artery
bypass surgery only in the hands of experienced operators.
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analysis using odds ratios was used as sensitivity analysis and
the results are given in Data S1.
The incidence rate ratio (IRR) was used for the long-term
outcomes.
Outcome Analyses
The primary outcome was all-cause mortality at the longest
reported follow-up.
The secondary outcomes were operative mortality, periop-
erative stroke, perioperative MI, and late repeated revascu-
larization.
To assess the hypotheses that the length of the follow-up,
the surgeons’ experience with OPCABG, and the complete-
ness of revascularization in the OPCABG arm could inﬂuence
the results of the comparison between the 2 techniques, we
performed the following subgroup analyses for the primary
outcome:
Length of the follow-up
Studies with a mean follow-up <3 years were compared with
studies with a mean follow-up ≥3 years.
Surgeons’ experience
The proportion of patients who crossed over from OPCABG to
ONCABG was used as a surrogate for surgeons’ experience
with OPCABG. We divided the included studies into 3 groups
according to the percentage of OPCABG crossover: ≤3%, >3,
and <10%, ≥10%.
Relative difference in the rate of incomplete
revascularization
We calculated the relative rate of incomplete revascularization
by dividing the rate of incomplete revascularization in the
OPCABG arm by the rate of incomplete revascularization in
the ONCABG arm and compared studies with a relative rate of
incomplete revascularization >2 to studies with a relative rate
of incomplete revascularization ≤2.
All boundaries for subgroup analysis were selected based
on the authors’ opinion and experience. For all subgroup
analyses, P value for subgroups differences was reported.
Statistical Analysis
Relative effect estimates were calculated as risk differences
and log IRRs with 95% conﬁdence intervals (95% CIs) for
short-term and long-term outcomes, respectively. We pooled
late outcomes as the natural logarithm of the IRR to account
for potentially different follow-up durations between different
treatments. We estimated the IRR through different means
depending on the available study data. When hazard ratios
were reported, we took the natural logarithm of the hazard
ratio with the standard error calculated from the 95% CI or log
rank P value. When Kaplan-Meier curves were available, event
rates were estimated from the curves using GetData Graph
Digitizer software 2.26 (http://getdata-graph-digitizer.com/)
and in case Kaplan-Meier curves were not available, we used
the reported event rates to calculate the IRR.7
IRRs were pooled using random effect model with generic
inverse variance (DerSimonian and Laird method);8 however,
we also reported ﬁxed-effect model results in Data S1.
Heterogeneity was reported as low (I2=0–25%), moderate
(I2=26–50%), and high (I2 >50%).9 In all comparisons, the
ONCABG group was used as a reference.
For the primary outcome, leave-1-out analysis and funnel
plot with trim-and-ﬁll method to assess for publication bias
were performed. Egger’s test together with visual inspection
were used to assess for funnel asymmetry.9 Univariate meta-
regression was used to assess the relationship between
the proportion of patients who crossed over from OPCABG to
ONCABG and the completeness of revascularization.
Restricted cubic spline analysis10 was used to assess the
effect of crossover on long-term mortality.
Meta and metaphor packages in R (version 3.3.3 R Project
for Statistical Computing) using Rstudio were used for
analyses. Review Manager (RevMan) v. 5.3 was used for risk
of bias assessment.
Results
Selected Studies
From 1906 titles, 160 pertinent studies were included for full-
text review. We excluded 56 studies that did not meet the
inclusion criteria. Further details of the study ﬂow are shown
in Figure S1. A total of 104 RCTs were selected for
the quantitative analysis (individual references are given in
Data S1).
The selected trials reported on 20 627 patients (OPCABG:
10 288; ONCABG: 10 339). The studies were published from
1995 to 2017, and the sample size ranged from 9 to 2375
patients.
Ten studies (3591 patients) had a mean follow-up <3 years
and 9 (8532 patients) had a mean follow-up ≥3 years. The
percentage of crossover was ≤3% in 6 studies, >3 to <10% in
8, and ≥10% in 4 studies, representing 33.3%, 44.4%, and
22.2% of all studies and 10.0%, 67.9%, and 22.1% of all
patients included in the subgroup analysis on long-term
mortality based on the crossover rate from OPCABG group,
respectively. The relative rate of incomplete revascularization
was ≤2% in 5 studies and >2% in 5 trials.
Overall, the OPCABG and ONCABG groups had similar
preoperative risk factor distributions: the mean age ranged
from 47.2 to 78.6 years in the OPCAB group versus 49.4 to
DOI: 10.1161/JAHA.118.010034 Journal of the American Heart Association 3
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78.4 years in the ONCAB. The rates of the most relevant
preoperative characteristics in the 2 groups were as follows:
male sex, 79.25% OPCABG versus 79.9% in the ONCABG;
hypertension 73.1% OPCABG versus 66.9% ONCABG, diabetes
mellitus 24.5% OPCABG versus 24.17% ONCABG, previous
stroke 8.45% OPCABG versus 7.99% ONCABG, previous MI
21.2% OPCABG versus 20.1% ONCABG (Table S1; details of
operative data are reported in Table S2).
Primary Outcome
The weighted mean follow-up time across the 19 studies that
reported long-term mortality was 3.7 years (range
1–7.5 years). The overall mortality rate at the end of follow-
up was 12.3% in the OPCABG versus 11.1% in the ONCABG
series.
There was a borderline statistically signiﬁcant excess risk
of mortality at follow-up in the OPCABG group (IRR 1.11, 95%
CI 1.00–1.23, P=0.05, Figure 1).3,4,11–36
Leave-1-out analysis and funnel plot with trim-and-ﬁll
method for the primary outcome are shown in Figure S2.
In the subgroup analysis based on the length of the mean
follow-up, late mortality was higher in the OPCABG group (IRR
1.16, 95% CI 1.01–1.34) in studies with ≥3-year follow-up
(Figure 2)3,4,11–36 and no different in studies with <3 years of
follow-up (IRR 0.93, 95% CI 0.72–1.20). The test for subgroup
difference was not signiﬁcant (Table S3, interaction P=0.13).
In the subgroup analysis based on the percentage of
crossover from the OPBAG group, there was no difference in
late mortality for studies with a crossover rate of ≤3% (IRR 0.96,
95% CI 0.60–1.42) or those with a crossover rate between 3%
and 10% (IRR 1.07, 95% CI 0.94–1.21). However, there was a
statistically signiﬁcant excess risk of late mortality in the
OPCABG group for studies with a crossover rate ≥10%
(Figure 3—IRR 1.30, 95% CI 1.04–1.62).3,4,11–14,16–36
The test for subgroup differences was not signiﬁcant
(Table S3—Interaction P=0.27) Assessment by restricted
cubic spline showed that the inﬂection point was around 9.5%
(b coefﬁcient=5.68, 95% CI 0.42–10.94, P=0.03) (Figure S3).
In the subgroup analysis based on completeness of
revascularization, there was no difference in mortality for
those with a high degree of incomplete revascularization
(Figure 4—IRR 1.16, 95% CI 0.91–1.48)* and those with a
lower degree of incomplete revascularization (IRR 0.81, 95%
CI 0.44–1.48). Test for subgroup differences was not
signiﬁcant (interaction P=0.28).
Figure 1. Long-term mortality. 95% CI indicates 95% conﬁdence
interval; IRR, incidence rate ratio; ONCABG, on-pump coronary artery
bypass surgery; OPCABG, off-pump coronary artery bypass surgery.
Figure 2. Long-term mortality in different subgroups based on
the length of follow-up. 95% CI indicates 95% conﬁdence interval;
IRR, incidence rate ratio; ONCABG, on-pump coronary artery
bypass surgery; OPCABG, off-pump coronary artery bypass
surgery.
*References3,4,11–13,15,19,20,22,24–26,30,32,33
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At meta-regression, there was a correlation between the
proportion of patients who crossed over from OPCABG to
ONCABG and the rate of incomplete revascularization in the
OPCABG arm (b=0.0019, P=0.03).
Secondary Outcomes
Operative mortality was 1.6% in the OPCABG group and 2.0%
in the ONCABG series. No signiﬁcant differences in operative
mortality (RD 0.17, 95% CI 0.53 to 0.19, P=0.37) and
perioperative MI (RD 0.4, 95% CI 0.95 to 0.15], P=0.15)
were found between the 2 groups. A nonsigniﬁcant trend
toward lower perioperative stroke in the OPCABG group was
evident (RD 0.34, 95% CI 0.68 to 0.00, P=0.05). The
difference in stroke became signiﬁcant when using odds ratio
instead of RD (Figures S4 through S9, Table S3).
The incidence of late repeated revascularization was not
statistically different between OPCABG and ONCABG,
although it was numerically higher in the OPCABG patients
(IRR 1.17, 95% CI 0.98–1.38) (Figure S10).
Discussion
This analysis was undertaken to address 3 important clinical
questions: the effect of the length of follow-up, the surgeons’
experience in OPCABG, and the completeness of revascular-
ization in the OPCABG arm in determining the results of the
comparison between the 2 techniques.
We found that:
1. The use of OPCABG was not associated with a decrease in
operative mortality. The perioperative outcome of the 2
groups was similar, although OPCABG was associated with
a reduced perioperative stroke rate. At follow-up, however,
there was a signiﬁcant increase in the risk of mortality for
patients who underwent OPCABG. A trend toward higher
risk of late repeated revascularization was also noted in
the off-pump series, supporting the hypothesis of less
effective coronary revascularization as the cause of the
difference in mortality.
2. Our ﬁndings of higher late mortality with OPCABGmay have
been driven by the length of study follow-up. While late
survival was similar for studies with a mean follow-up of
<3 years, there was a signiﬁcant difference in mortality in
favor of ONCABG when the study follow-up was >3 years.
3. We used the proportion of patients who crossed over from
OPCABG to ONCABG as a surrogate for surgeons’
experience. At subgroup analysis we found no difference
in late mortality in studies with low crossover (0%–10%).
However, in studies with 10% or higher crossover, survival
was signiﬁcantly reduced in the off-pump group.
Figure 3. Long-term mortality in different subgroups based on
the crossover rate from OPCABG group. 95% CI indicates 95%
conﬁdence interval; IRR, incidence rate ratio; ONCABG, on-pump
coronary artery bypass surgery; OPCABG, off-pump coronary
artery bypass surgery.
Figure 4. Long-term mortality in different subgroups based on
the relative rate of incomplete revascularization. 95% CI indicates
95% conﬁdence interval; IR, incomplete revascularization; IRR,
incidence rate ratio; ONCABG, on-pump coronary artery bypass
surgery; OPCABG, off-pump coronary artery bypass surgery.
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4. Although our subgroup analysis examining the degree of
incomplete revascularization found no statistical differ-
ence between OPCABG and ONCABG, visually, it appeared
that those with a higher degree of incomplete revascular-
ization had worst survival compared with those with less
incomplete revascularization.
5. As the percentage of crossover from the OPCABG group
increased, the rate of incomplete revascularization in the
off-pump arm also increased.
In the past 3 years, 3 meta-analyses comparing OPCABG and
ONCABG have been published. Deppe and colleagues exam-
ined 51 RCTs and combined data of 16 904 patients.37 They
found similar incidence of major adverse cardiac and cere-
brovascular events in the off- and on pump series at 30 days
and long-term follow-up. Of note, the authors used odds ratios
as estimators of risk even for long-term outcomes.
Kowalewski and associates pooled data from 100 RCTs
and 19 192 patients to compare short-term outcomes
between the 2 techniques.38 The authors reported signiﬁ-
cantly lower risk of stroke in the OPCABG arm and no
differences in mortality and MI between groups.
Filardo et al, in a meta-analysis of 42 RCTs and 31 risk-
adjusted observational studies, found lower short-term mor-
tality but an excess of 10% in 5-year mortality for OPCABG.39
Our analysis includes 2 large recently published trials
comparing OPCABG to ONCABG3,4 for a total of 104 RCTs and
20 627 patients.
Contrary to previous analyses, we have used IRR for time-
to-event outcomes in order to account for the difference in
follow-up among the different trials. Because of the demon-
strated variation of the results of the comparison between
OPCABG and ONCABG with the time, adjusting for the length
of follow-up seems particularly important in this type of
analysis. Also, we focused on RCTs only, to avoid unmatched
confounder and bias intrinsic to observational studies com-
paring different surgical techniques40 and provide a synthesis
of the best possible evidence.
Another novel aspect of this meta-analysis includes the
examination of the relationship between surgical conﬁdence
with OPCABG and long-term survival. OPCABG is technically
more challenging than ONCABG, and it has been shown that
the volume–outcome effect is much steeper for off-pump
procedures.41 We used crossover from the OPCABG arm as a
surrogate of surgeons’ experience and we postulated an
inverse relationship between crossover and surgeons’ conﬁ-
dence with OPCABG. The results support this hypothesis
because the mortality beneﬁt of ONCABG was greater in the
higher crossover studies than in the studies with a low
conversion rate.
While some crossover of patients who were initially
assigned to OPCABG is inevitable because of patient anatomy,
a high crossover rate suggests that surgeon experience may
be lacking in expertly performing off-pump surgery or
predicting which patients will best tolerate off-pump surgery.
In a retrospective review of the Nationwide Inpatient Sample
of over 2 million patients undergoing CABG, we previously
showed that multivessel OPCABG performed at low OPCABG
volume centers or by low volume surgeons is associated with
increased mortality.41
Completeness of revascularization is likely related to the
surgeon experience and comfort with the more complex off-
pump technique. In our analysis, we found a trend toward
better OPCABG results for studies with higher rate of
complete revascularization in the off-pump group. Of note,
there was a statistically signiﬁcant correlation between the
percentage of crossover from the OPCABG group and the
completeness of revascularization in the off-pump series,
suggesting that both may be consequences of surgeon
experience.
Taken together, those ﬁndings suggest that surgeon’s
comfort with OPCABG plays an important role in determining
the results of the technique and the comparison with
ONCABG. More experienced OPCABG teams (including car-
diac surgeons, cardiac anesthesiologists, scrub nurses, and
technicians) have lower crossover rate, achieve higher rate of
complete revascularization, and have results similar to those
of ONCABG.
A purported beneﬁt of OPCABG includes a reduction of
neurological events or stroke as a result of minimal or no
aortic manipulation. In our meta-analysis, a trend toward
reduced perioperative stroke in the off-pump arm was noted,
but this difference did not reach statistical signiﬁcance. Wide
heterogeneity in off-pump practices may explain this ﬁnding—
techniques range from complete anaortic to the use of a side-
biting clamp for construction of the proximal anastomoses. A
meta-analysis of mostly observational studies that compared
anaortic OPCABG to OPCABG that involved aortic manipula-
tion with a side-biting clamp showed a 61% risk reduction in
stroke with the anaortic technique.42 However, all RCTs that
compare OPCABG to ONCABG allowed for variation in the
procedural conduct of CABG; thus, the separation of anaortic
versus the use of a partial clamp is not possible in a meta-
analysis of RCTs. Furthermore, the use of an anaortic
technique may increase the arterial graft utilization (namely,
a bilateral internal thoracic artery grafting strategy), which
may bias results towards OPCABG. Of note, improved
neurological outcomes with ONCABG have been described
with the use of the single cross-clamp technique.43
This study must be interpreted in the context of some
important limitations. Intrinsic to any meta-analysis is a
concern for publication bias. However, our funnel plot analysis
for the primary outcome suggests that there was no large
publication bias. The enrolled trials did not standardize the
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details of the surgical technique. There was wide variation in
how both the OPCABG and ONCABG was performed, in
particular with respect to aortic manipulation and the number
and type of arterial grafts used. Furthermore, heterogeneity in
our study was low, suggesting that these differences may
have been minimal.
We used subgroup analyses to explore the potential effect
of length of the follow-up, cross-over, and completeness of
revascularization on the primary outcome. We acknowledge
that post hoc subgroup analyses are only hypothesis gener-
ating and that the number of studies in each subgroup was
limited (despite having a large total sample size). Also, we
established the boundaries between subgroups mainly based
on our clinical judgment and expertise and not using a purely
statistical method. However, we did conduct a cubic spline
analysis, which suggested that a 10% crossover rate may be
the threshold for differences in late mortality. Because this
analysis was meant to answer a clinically relevant question
based on surgical considerations, we decided to privilege a
clinical rather than statistical approach, but this is open to
critique. The use of crossover as a marker of surgeons’
experience has intrinsic limitations and may also be criticized.
Furthermore, we recognize that by performing multiple
subgroup analyses without correction, there is an increased
risk for type 1 error (ie, false-positive results) in our observed
patterns.
In addition, we could not specify the cause of follow-up
death as well as the reasons for crossing over, and we had no
information on the use of multiple arterial grafts (a potential
effect modiﬁer for long-term outcomes) and on the details of
the surgical technique used, in particular regarding the degree
of aortic manipulation (a potential modiﬁer for short-term
outcomes, especially perioperative stroke). Also, we could not
capture the reason for crossover. This is particularly relevant
because the reason for conversion to ONCABG itself might
inﬂuence patients’ outcomes. In an analysis of the Society of
Thoracic Surgeons Adult Cardiac Database,44 patients con-
verted for hemodynamic instability or bleeding (representing
37.2% of all conversions) had an in-hospital mortality rate of
6.4% (observed-to-expected ratio, 2.38), whereas patients
converted for poor visualization (representing 13.2% of all
conversions) had an in-hospital mortality of 2.4% (observed-
to-expected ratio, 1.33).
Finally, while we showed that the proportion of crossover
may have an impact on the primary outcome, we do not have
enough information to explain the mechanism—whether it
could be related to surgeon’s experience or a dilution of the
true treatment beneﬁt with OPCABG because of intention-
to-treat analysis in the RCT.
In summary, this meta-analysis represents a comprehen-
sive summary of RCTs comparing OPCABG to ONCABG. Our
results showed that OPCABG was associated with no
reduction in operative risk, an excess mortality at follow-up
≥3 years, and a trend toward higher risk of repeated
revascularization.
We hypothesize that a surgeon’s experience in OPCABG
may be associated with late mortality and that OPCABG can
be comparable to ONCABG only in the hands of experienced
operators.
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None.
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